Rafael Holdings, Inc.
RFL- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001713863
No open-market purchases or sales by Rafael Holdings, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $12.7M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Rafael Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Rafael Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Polinsky David | Chief Financial Officer | 297,084 | Sep 23, 2026 | 6 |
| Jonas Howard S | Exec Chairman, CEO & President | 512,030 | Jul 31, 2026 | 5 |
| Sieger Markus | Director | 219,710 | Jan 30, 2026 | 1 |
| Weiss Michael J | Director | 141,861 | Jan 29, 2026 | 1 |
| Stein Mark N | Director | 50,845 | Jan 29, 2026 | 1 |
| Grayson Alan | Director | 6,562 | Jan 29, 2026 | 1 |
| Fine Joshua M | Chief Operating Officer | – | Sep 5, 2025 | 0 |
| Conkling William | Chief Executive Officer | 564,455 | Apr 24, 2025 | 0 |
| Goldberg John | CHIEF MEDICAL OFFICER | 50,000 | Jan 15, 2025 | 0 |
| Greenberg Stephen M | Director | 102,491 | Jan 8, 2025 | 0 |
| McCamish Mark Anthony | Director | 60,241 | Jan 8, 2024 | 0 |
| Pasche Boris C | Director | 47,295 | Jan 5, 2023 | 0 |
| Fabbio Patrick | CFO & President | 335,175 | Dec 23, 2022 | 0 |
| i9 PLUS, LLC | 10% Owner | 3,225,806 | Aug 9, 2022 | 0 |
| Mallik Ameet | Director | 0 | Apr 12, 2022 | 0 |
| Klinger Shannon Thyme | Director | 5,412 | Jan 5, 2022 | 0 |
| Huizinga Mary Margaret | Chief Devel. & Medical Officer | – | Oct 19, 2021 | 0 |
| Marin Ashok D | Chief Legal Officer | – | Sep 28, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 (view filing) | Jun 5 | 4 days | Jonas Howard SExec Chairman, CEO & President | PPurchaseClass B Common Stock, $.01 par value per share | +13.1M | $1.28 | +$16.7M | New position12.3M after | 3 lots |
| Aug 9, 2022 (view filing) | Aug 5-9 | 4 days | Jonas Howard SExecutive Chairman | SSaleClass B Common Stock, par value $.01 per share | −112.6K | $1.88 | −$211.6K | −3.4%3.23M after | 3 lotsDuplicate filing |
| Aug 9, 2022 (view filing) | Aug 5-9 | 4 days | i9 PLUS, LLC10% Owner | SSaleClass B Common Stock par value $.01 per share | −112.6K | $1.88 | −$211.6K | −3.4%3.23M after | 3 lots |
| Jul 7, 2022 (view filing) | Jul 6 | 1 day | Jonas Howard SExecutive Chairman | PPurchaseClass B Common Stock, par value $.01 per share | +3.23M | $1.86 | +$6.00M | +2,865.8%3.34M after | |
| Aug 25, 2021 (view filing) | Aug 24 | 1 day | Jonas Howard SChief Executive Officer | PPurchaseClass B Common Stock, par value $.01 per share | +112.6K | $44.92 | +$5.06M | New position112.6K after |